Table 1 Comparison between the characteristics of male and female HCCs

Age

57.7 ± 14.3

56.2 ± 13.8

0.310

Anti-HCV positive, n (%)

44 (37.3%)

91 (22.9%)

0.002

HBsAg positive, n (%)

70 (59.3%)

289 (72.6%)

0.006

Liver cirrhosis, n (%)

67 (56.8%)

230 (57.8%)

0.846

Non-cirrhosis, ALT <2×ULN^a, n (%)

43 (36.4%)

125 (31.4%)

0.361

Non-cirrhosis, ALT >2×ULN, n (%)

8 (6.8%)

43 (10.8%)

0.267

Microvascular invasion, n (%)

29 (24.6%)

144 (36.2%)

0.019

Macrovascular invasion, n (%)

13 (11.0%)

54 (13.6%)

0.469

 < 3

54 (45.8%)

179 (45.0%)

0.964

 >= 3

64 (54.2%)

219 (55.0%)

Capsule, n (%)

86 (72.9%)

289 (72.6%)

0.954

Tumor number

0.817

 1

74 (62.7%)

232 (58.3%)

 2

27 (22.9%)

89 (22.4%)

 3

13 (11.0%)

54 (13.6%)

 > 3

4 (3.4%)

23 (5.8%)

Ascites, n (%)

8 (6.8%)

31 (7.8%)

0.716

Alcoholism, n (%)

3 (2.5%)

130 (32.7%)

< 0.001

Largest tumor size, cm

5.9 ± 4.3

6.0 ± 5.4

0.715

AFP, ng/mL

25 (< 1 – 286980)

58.4 (1.1 – 685353)

0.023

Albumin, g/L

3.9 ± 0.6

4.0 ± 0.6

0.174

Bilirubin, mg/dL

0.9 ± 0.6

1.2 ± 1.4

0.002

Prothrombin time, sec

11.9 ± 1.4

12.2 ± 1.4

0.051

Creatinine, mg/dL

1.0 ± 1.1

1.2 ± 1.0

0.125

AST, U/L

70.0 ± 84.8

70.0 ± 99.0

0.960

ALT, U/L

53.7 ± 50.5

79.7 ± 125.3

0.001